EBCOF Quote, Financials, Valuation and Earnings

Japan Food Tech Holdings has a net margin of 5.63% compared to Ebara's net margin of -1471.96%. Ebara's return on equity of 15.27% beat Japan Food Tech Holdings's return on equity of -241.02%.

Ebara has a consensus price target of --, signalling downside risk potential of --. On the other hand Japan Food Tech Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Ebara has higher upside potential than Japan Food Tech Holdings, analysts believe Ebara is more attractive than Japan Food Tech Holdings.

Ebara has a beta of 0.565, which suggesting that the stock is 43.5% less volatile than S&P 500. In comparison Japan Food Tech Holdings has a beta of 45.515, suggesting its more volatile than the S&P 500 by 4451.471%.

Ebara has a quarterly dividend of $0.15 per share corresponding to a yield of 1.86%. Japan Food Tech Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ebara pays 31.42% of its earnings as a dividend. Japan Food Tech Holdings pays out -- of its earnings as a dividend. Ebara's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ebara quarterly revenues are $1.4B, which are larger than Japan Food Tech Holdings quarterly revenues of $5.5K. Ebara's net income of $79.6M is higher than Japan Food Tech Holdings's net income of -$81.3K. Notably, Ebara's price-to-earnings ratio is 16.18x while Japan Food Tech Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ebara is 1.33x versus 32.31x for Japan Food Tech Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Kubota has a net margin of 5.63% compared to Ebara's net margin of 6.75%. Ebara's return on equity of 15.27% beat Kubota's return on equity of 9.86%.

Ebara has a consensus price target of --, signalling downside risk potential of --. On the other hand Kubota has an analysts' consensus of -- which suggests that it could grow by 42.32%. Given that Kubota has higher upside potential than Ebara, analysts believe Kubota is more attractive than Ebara.

Ebara has a beta of 0.565, which suggesting that the stock is 43.5% less volatile than S&P 500. In comparison Kubota has a beta of 0.968, suggesting its less volatile than the S&P 500 by 3.175%.

Ebara has a quarterly dividend of $0.15 per share corresponding to a yield of 1.86%. Kubota offers a yield of 2.84% to investors and pays a quarterly dividend of $0.85 per share. Ebara pays 31.42% of its earnings as a dividend. Kubota pays out 22.85% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ebara quarterly revenues are $1.4B, which are smaller than Kubota quarterly revenues of $4.7B. Ebara's net income of $79.6M is lower than Kubota's net income of $317.2M. Notably, Ebara's price-to-earnings ratio is 16.18x while Kubota's PE ratio is 8.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ebara is 1.33x versus 0.67x for Kubota. Usually stocks with elevated PS ratios are considered overvalued.

Kyocera has a net margin of 5.63% compared to Ebara's net margin of 7.38%. Ebara's return on equity of 15.27% beat Kyocera's return on equity of 3.11%.

Ebara has a consensus price target of --, signalling downside risk potential of --. On the other hand Kyocera has an analysts' consensus of $11.05 which suggests that it could grow by 10.72%. Given that Kyocera has higher upside potential than Ebara, analysts believe Kyocera is more attractive than Ebara.

Ebara has a beta of 0.565, which suggesting that the stock is 43.5% less volatile than S&P 500. In comparison Kyocera has a beta of 0.272, suggesting its less volatile than the S&P 500 by 72.817%.

Ebara has a quarterly dividend of $0.15 per share corresponding to a yield of 1.86%. Kyocera offers a yield of 3.22% to investors and pays a quarterly dividend of $0.17 per share. Ebara pays 31.42% of its earnings as a dividend. Kyocera pays out 73.91% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ebara quarterly revenues are $1.4B, which are smaller than Kyocera quarterly revenues of $3.2B. Ebara's net income of $79.6M is lower than Kyocera's net income of $236M. Notably, Ebara's price-to-earnings ratio is 16.18x while Kyocera's PE ratio is 20.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ebara is 1.33x versus 1.04x for Kyocera. Usually stocks with elevated PS ratios are considered overvalued.

SBC Medical Group Holdings has a net margin of 5.63% compared to Ebara's net margin of 5.34%. Ebara's return on equity of 15.27% beat SBC Medical Group Holdings's return on equity of 25.89%.

Ebara has a consensus price target of --, signalling downside risk potential of --. On the other hand SBC Medical Group Holdings has an analysts' consensus of -- which suggests that it could grow by 101.84%. Given that SBC Medical Group Holdings has higher upside potential than Ebara, analysts believe SBC Medical Group Holdings is more attractive than Ebara.

Ebara has a beta of 0.565, which suggesting that the stock is 43.5% less volatile than S&P 500. In comparison SBC Medical Group Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Ebara has a quarterly dividend of $0.15 per share corresponding to a yield of 1.86%. SBC Medical Group Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ebara pays 31.42% of its earnings as a dividend. SBC Medical Group Holdings pays out -- of its earnings as a dividend. Ebara's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ebara quarterly revenues are $1.4B, which are larger than SBC Medical Group Holdings quarterly revenues of $53.1M. Ebara's net income of $79.6M is higher than SBC Medical Group Holdings's net income of $2.8M. Notably, Ebara's price-to-earnings ratio is 16.18x while SBC Medical Group Holdings's PE ratio is 12.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ebara is 1.33x versus 2.51x for SBC Medical Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.